Skip to main content
logo
CBD Life Sciences Inc. (CBDL)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Sep 4, 2026

CBD Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
112008
Market Cap Growth
37.29%-24.91%3469.86%4.42%-99.50%62.45%
Enterprise Value
112-0-08
Last Close Price
0.000.000.000.000.000.06

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
12.0711.5915.600.250.2597.63
PB Ratio
1.581.524.051.000.306.11
P/TBV Ratio
2.041.967.62--6.98
P/FCF Ratio
--101.05---
P/OCF Ratio
--101.05---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.3712.2616.27--98.38
EV/FCF Ratio
--105.44---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.44-0.44-0.02-0.060.00-0.77
Net Debt / EBITDA Ratio
--0.010.110.00-
Net Debt / FCF Ratio
2.382.38-0.440.150.000.16
Asset Turnover
0.170.170.310.610.19-
Inventory Turnover
1.701.702.146.042.75-
Quick Ratio
14.2114.2114.930.010.00-
Current Ratio
15.1215.1217.180.120.05-
Return on Equity (ROE)
-8.71%-8.71%-362.96%-88.73%-117.18%-930.04%
Return on Assets (ROA)
-10.81%-10.81%-150.65%-17.95%-64.47%-
Return on Capital Employed (ROCE)
-13.60%-13.60%-203.40%-184.40%-639.30%-450.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.12%-4.29%-49.90%-184.85%-2112.23%-75.43%
FCF Yield
-11.73%-12.21%0.99%-39.15%-2145.09%-79.16%
Buyback Yield / Dilution
-2929.02%-540.48%-372.93%--73.92%-2403.73%